{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70000-0719",
      "generic_name": "guaifenesin, pseudoephedrine hydrochloride",
      "labeler_name": "Cardinal Health 110, LLC. dba Leader",
      "brand_name": "Leader Mucus Relief D",
      "active_ingredients": [
        {
          "name": "GUAIFENESIN",
          "strength": "1200 mg/1"
        },
        {
          "name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
          "strength": "120 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70000-0719-1",
          "description": "4 BLISTER PACK in 1 CARTON (70000-0719-1)  / 6 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20250308",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Cardinal Health 110, LLC. dba Leader"
        ],
        "rxcui": [
          "1244675"
        ],
        "spl_set_id": [
          "12971fb2-2314-4443-bf70-b7eb5859b148"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "495W7451VQ",
          "6V9V2RYJ8N"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, MULTILAYER, EXTENDED RELEASE",
      "spl_id": "1a7ee5d9-d68a-4df4-ac73-21002330b66a",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250308",
      "product_id": "70000-0719_1a7ee5d9-d68a-4df4-ac73-21002330b66a",
      "application_number": "ANDA214407",
      "brand_name_base": "Leader Mucus Relief D",
      "pharm_class": [
        "Adrenergic alpha-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "alpha-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}